- Home
- / Evogene
Evogene
Stock Price
$2.4
2024-10-29
Market Capitalization
$12.9 M
2024-10-29
Revenue
$3.9 M
FY, 2025
Evogene Summary
Company Summary
- Overview
- Evogene is a biotechnology company that develops products for life science markets through the use of a predictive biology platform. It utilizes computational biology technologies to produce agrochemical, agrobiological, and agroseed products.
- Type
- Public
- Status
- Active
- Founded
- 1999
- HQ
- Rehovot, IL | view all locations
- Website
- https://www.evogene.com/
- Cybersecurity rating
- ESG rating
Table of Contents
LocationsView all
1 location detected
Rehovot, Center District HQ
Israel
Rehovot HaHolandit Park, Har HaTsofim St 15
Evogene Financials
Summary Financials
- Revenue (Q1, 2026)
- $334.0K
- Gross profit (Q1, 2026)
- $234.0K
- Net income (Q1, 2026)
- ($5.9M)
- Cash (Q1, 2026)
- $8.5M
- EBIT (Q1, 2026)
- ($3.2M)
- Enterprise value
- $6.5M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026